Literature DB >> 14706811

The intestinal H+/peptide symporter PEPT1: structure-affinity relationships.

Matthias Brandsch1, Ilka Knütter, Frederick H Leibach.   

Abstract

Peptide transporter 1, PEPT1, of the mammalian enterocyte is presently under intense investigation in many laboratories because of its nutritional importance in the absorption of protein hydrolysis products and because more recent studies have shown that many drugs and prodrugs gain entry into the systemic circulation via PEPT1. Until the exact structural features of the substrate binding site of PEPT1 become available, for example by X-ray crystallography, determination of affinities followed by proof of actual membrane translocation will have to suffice when testing for possible new substrates for PEPT1. Affinity constants reflect the strength of their interaction with the binding site of the transporter. A review of the literature shows a wide range of affinity constants between 2 microM and 30 mM. We consider affinity constants for substrates or inhibitors of PEPT1 lower than 0.5 mM as high affinity, between 0.5 and 5.0 mM as medium affinity and above 5 mM as low affinity. Values above 15 mM we consider with great caution. In this mini-review we discuss affinities and structural determinants which affect affinities of a variety of substrates for PEPT1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14706811     DOI: 10.1016/s0928-0987(03)00142-8

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  15 in total

1.  Enzymatic activation of double-targeted 5'-O-L-valyl-decitabine prodrug by biphenyl hydrolase-like protein and its molecular design basis.

Authors:  Wenhui Tao; Dongyang Zhao; Mengchi Sun; Meng Li; Xiangyu Zhang; Zhonggui He; Yinghua Sun; Jin Sun
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

2.  In vitro and pharmacophore-based discovery of novel hPEPT1 inhibitors.

Authors:  Sean Ekins; Jeffrey S Johnston; Praveen Bahadduri; Vanessa M D'Souza; Abhijit Ray; Cheng Chang; Peter W Swaan
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

3.  The proton-coupled amino acid transporter, SLC36A1 (hPAT1), transports Gly-Gly, Gly-Sar and other Gly-Gly mimetics.

Authors:  S Frølund; R Holm; B Brodin; C U Nielsen
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

4.  PepT1 mediates transport of the proinflammatory bacterial tripeptide L-Ala-{gamma}-D-Glu-meso-DAP in intestinal epithelial cells.

Authors:  Guillaume Dalmasso; Hang Thi Thu Nguyen; Laetitia Charrier-Hisamuddin; Yutao Yan; Hamed Laroui; Benjamin Demoulin; Shanthi V Sitaraman; Didier Merlin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-17       Impact factor: 4.052

5.  Delta-aminolevulinic acid is a substrate for the amino acid transporter SLC36A1 (hPAT1).

Authors:  S Frølund; O C Marquez; M Larsen; B Brodin; C U Nielsen
Journal:  Br J Pharmacol       Date:  2010-01-27       Impact factor: 8.739

6.  Enhancing the intestinal absorption of molecules containing the polar guanidino functionality: a double-targeted prodrug approach.

Authors:  Jing Sun; Arik Dahan; Gordon L Amidon
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

7.  Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine.

Authors:  Michael Pennick
Journal:  Neuropsychiatr Dis Treat       Date:  2010-06-24       Impact factor: 2.570

8.  Evidence of D-phenylglycine as delivering tool for improving L-dopa absorption.

Authors:  Chun-Li Wang; Yang-Bin Fan; Hsiao-Hwa Lu; Tung-Hu Tsai; Ming-Cheng Tsai; Hui-Po Wang
Journal:  J Biomed Sci       Date:  2010-09-06       Impact factor: 8.410

9.  Development of a QSAR model for binding of tripeptides and tripeptidomimetics to the human intestinal di-/tripeptide transporter hPEPT1.

Authors:  Rikke Andersen; Flemming Steen Jørgensen; Lars Olsen; Jon Våbenø; Karina Thorn; Carsten Uhd Nielsen; Bente Steffansen
Journal:  Pharm Res       Date:  2006-02-26       Impact factor: 4.200

10.  A charge pair interaction between Arg282 in transmembrane segment 7 and Asp341 in transmembrane segment 8 of hPepT1.

Authors:  Ashutosh A Kulkarni; Daryl L Davies; Jennifer S Links; Leena N Patel; Vincent H L Lee; Ian S Haworth
Journal:  Pharm Res       Date:  2006-09-29       Impact factor: 4.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.